Anti‐IL‐5 therapies for #COPD - https://t.co/mV9YqS2Doj - New @CochraneAirways #visualabstract from @ascheely @cg_coleman & @EmoryMedicine https://t.co/mPipO7Bbiy
RT @CochraneAirways: Here's the visual abstract for the review on Anti-IL5 therapy for COPD. Full review available here https://t.co/5gMDY0…
RT @cochranecollab: Anti‐IL‐5 therapies for #COPD - https://t.co/KnpXeHYiwz - New @CochraneAirways #visualabstract from @ascheely @cg_colem…
Anti‐IL‐5 therapies for #COPD - https://t.co/KnpXeHYiwz - New @CochraneAirways #visualabstract from @ascheely @cg_coleman & @EmoryMedicine https://t.co/YlOyrytSXv
RT @CochraneAirways: Here's the visual abstract for the review on Anti-IL5 therapy for COPD. Full review available here https://t.co/5gMDY0…
RT @CochraneLibrary: Anti‐IL‐5 therapies for #COPD - https://t.co/mV9YqS2Doj - New @CochraneAirways visual abstract from @ascheely @cg_cole…
RT @CochraneAirways: Here's the visual abstract for the review on Anti-IL5 therapy for COPD. Full review available here https://t.co/5gMDY0…
RT @CochraneAirways: Thrilled with our first visual abstract created by Amy and Sean. What do you think? Would you like to see more of thes…
RT @pulmonology101: @Majito25MD @julipsb
RT @CochraneLibrary: Anti‐IL‐5 therapies for #COPD - https://t.co/mV9YqS2Doj - New @CochraneAirways visual abstract from @ascheely @cg_cole…
@Majito25MD @julipsb
RT @CochraneLibrary: Anti‐IL‐5 therapies for #COPD - https://t.co/mV9YqS2Doj - New @CochraneAirways visual abstract from @ascheely @cg_cole…
Here's the visual abstract for the review on Anti-IL5 therapy for COPD. Full review available here https://t.co/5gMDY0s7bp https://t.co/ASiIf2UdN3
Anti‐IL‐5 therapies for #COPD - https://t.co/mV9YqS2Doj - New @CochraneAirways visual abstract from @ascheely @cg_coleman & @EmoryMedicine https://t.co/OidWXfelhR
Thrilled with our first visual abstract created by Amy and Sean. What do you think? Would you like to see more of these for Cochrane Reviews? #COPD https://t.co/5gMDY0s7bp
Working with the @CochraneAirways team as a statistician has been one of the highlights of 2020! I am thankful to them for showing me the ropes of meta-analyses and giving me the opportunity to work on some exciting systematic reviews as I start my career
RT @CochraneLibrary: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/mV9YqS2Doj New @C…
RT @CochraneLibrary: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/mV9YqS2Doj New @C…
RT @CochraneLibrary: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/mV9YqS2Doj New @C…
RT @CochraneLibrary: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/mV9YqS2Doj New @C…
Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/mV9YqS2Doj New @CochraneAirways systematic review includes six studies involving a total of 5542 participants.
RT @CochraneUK: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/94uNNi4mKa New @Cochra…
RT @CochraneUK: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/94uNNi4mKa New @Cochra…
RT @CochraneUK: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/94uNNi4mKa New @Cochra…
RT @CochraneUK: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/94uNNi4mKa New @Cochra…
RT @CochraneUK: Mepolizumab or benralizumab for people with chronic obstructive pulmonary disease #COPD https://t.co/94uNNi4mKa New @Cochra…
When your dad decides to jump on the respiratory train ..... https://t.co/1oX6yEi7ug
@Majito25MD @milenag71673854
RT @iainxingham: Anti IL5 drugs are generally disappointing in #COPD. Perhaps the trials didn't focus on a sufficiently eosinophilic popula…
Anti IL5 drugs are generally disappointing in #COPD. Perhaps the trials didn't focus on a sufficiently eosinophilic population? https://t.co/ZzWpTdcVyF @CochraneAirways